Merck Serono SA

Suisse

 
Quantité totale PI 126
Quantité totale incluant filiales 530 (+ 404 pour les filiales)
Rang # Quantité totale PI 10 083
Note d'activité PI 1,6/5.0    7
Rang # Activité PI 131 503
Activité incl filiales 2,5/5.0    115
Parent Merck KGAA

Brevets

Marques

48 0
16 0
62 0
0
 
Dernier brevet 2021 - Alpha-amino esters of hydroxypro...
Premier brevet 1987 - Site-directed mutagenesis modifi...

Filiales

4 subsidiaries with IP (372 patents, 32 trademarks)

3 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2020 Invention Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal pol...
Invention Methods of treating pruritic disease with il-31 monoclonal antibodies. The invention provides hum...
Invention Cladribine regimen for treating multiple sclerosis. The present invention relates to the use of ...
2018 Invention Membrane bound reporter molecules and their use in cell sorting. The present invention relates to...
Invention Nucleic acid molecules encoding humanized il-31 monoclonal antibodies. The invention provides hum...
Invention Cladribine regimen for treating multiple sclerosis. The present invention relates to the use of m...
2017 Invention Method of treating pruritus with il-31 monoclonal antibody formulations. The invention provides h...
Invention L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph t...
2016 Invention Il-31 monoclonal antibody formulations. The invention provides humanized mouse anti-human IL-31 a...
Invention Α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymor...
2015 Invention Expression vectors comprising the mcmv ie2 promoter. The invention relates to an expression vect...
Invention Method of treating pruritus with il-31 monoclonal antibodies. The invention provides humanized mo...
2014 Invention Puro-dhfr quadrifunctional marker and its use in protein production. This invention relates to in...
Invention Thiazole derivatives and use thereof. The present invention is related to thiazole derivatives of...
Invention Polynucleotides encoding il-31 monoclonal antibodies. The invention provides humanized mouse anti...
Invention Peptide. There is provided a peptide which is capable of binding to an MHC molecule in vitro and ...
2013 Invention Benzothiazole derivatives for the treatment of diabetes. The present invention is related to the...
Invention 3-arylamino pyridine derivatives. The invention provides novel, substituted 3-arylamino pyridine ...
Invention Jnk inhibitors for the treatment of endometriosis. This invention relates to a method of treatin...
Invention Nucleic acid molecules encoding humanized antibody molecules specific for il-31. The invention pr...
Invention Jnk inhibitors for the treatment of endometriosis. This invention relates to a method of treating...
Invention Piperazine derivatives and methods of use. The invention provides 2-carboxamide piperazine compou...
2012 Invention 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine ...
Invention Oxadiazole diaryl compounds. The invention relates to compounds of formula (I): c and W, have th...
Invention Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones. The present invention is ...
Invention Triazolopyridine compounds and their use as ask inhibitors. The present invention relates to tri...
Invention Process for the purification of fc-containing proteins. The invention relates to a process for t...
Invention Low fucose cell lines and uses thereof. A method of selecting cells having zero fucose level usef...
2011 Invention Membrane bound reporter molecules and their use in cell sorting. The present invention relates t...
Invention Indazolyl triazol derivatives. Compounds of Formula (I) are used for the treatment of inflammat...
Invention Indazolyl triazole derivatives as irak inhibitors. Compounds of Formula (I) are used for the trea...
Invention Antibody with specificity for gm-csf (ii). The present invention relates to antibodies with speci...
Invention Antibody with specificity for gm-csf (i). The present invention relates to antibodies with specif...
Invention Nucleic acid molecules encoding bank1 splice variants. The present invention relates to a new sp...
Invention Genomic markers for prediction of long-term response to growth hormone (gh) therapy. The present ...
Invention 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphat...
2010 Invention Tricyclic pyrazol amine derivatives. This invention relates to compounds of Formula (I*) as Pi3k ...
Invention Humanized antibodies against human il-22ra. The invention relates to humanized antibodies against...
1998 Invention Disulfide crosslinked glycoprotein hormone analogs, and their preparation and use. The invention ...